WO2015092813A3 - Lyophilized compositions comprising isomalt - Google Patents

Lyophilized compositions comprising isomalt Download PDF

Info

Publication number
WO2015092813A3
WO2015092813A3 PCT/IN2014/000748 IN2014000748W WO2015092813A3 WO 2015092813 A3 WO2015092813 A3 WO 2015092813A3 IN 2014000748 W IN2014000748 W IN 2014000748W WO 2015092813 A3 WO2015092813 A3 WO 2015092813A3
Authority
WO
WIPO (PCT)
Prior art keywords
isomalt
lyophilized compositions
lyophilized
compositions
preparing
Prior art date
Application number
PCT/IN2014/000748
Other languages
French (fr)
Other versions
WO2015092813A2 (en
Inventor
Bandi Parthasaradhi Reddy
Podili Khadgapathi
Bandari Sreedhar
Original Assignee
Hetero Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Research Foundation filed Critical Hetero Research Foundation
Publication of WO2015092813A2 publication Critical patent/WO2015092813A2/en
Publication of WO2015092813A3 publication Critical patent/WO2015092813A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to lyophilized pharmaceutical compositions comprising isomalt and process for preparing the same.
PCT/IN2014/000748 2013-12-16 2014-12-02 Lyophilized compositions comprising isomalt WO2015092813A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN5858/CHE/2013 2013-12-16
IN5858CH2013 IN2013CH05858A (en) 2013-12-16 2014-12-02

Publications (2)

Publication Number Publication Date
WO2015092813A2 WO2015092813A2 (en) 2015-06-25
WO2015092813A3 true WO2015092813A3 (en) 2015-08-27

Family

ID=53403844

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2014/000748 WO2015092813A2 (en) 2013-12-16 2014-12-02 Lyophilized compositions comprising isomalt

Country Status (2)

Country Link
IN (1) IN2013CH05858A (en)
WO (1) WO2015092813A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100080829A1 (en) * 2007-04-11 2010-04-01 Cephalon France Lyophilized pharmaceutical compositions and methods of making and using same
US8541360B2 (en) * 2008-11-19 2013-09-24 Ben Venue Laboratories, Inc. Parenteral formulations comprising sugar-based esters and ethers

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100080829A1 (en) * 2007-04-11 2010-04-01 Cephalon France Lyophilized pharmaceutical compositions and methods of making and using same
US8541360B2 (en) * 2008-11-19 2013-09-24 Ben Venue Laboratories, Inc. Parenteral formulations comprising sugar-based esters and ethers

Also Published As

Publication number Publication date
WO2015092813A2 (en) 2015-06-25
IN2013CH05858A (en) 2015-06-19

Similar Documents

Publication Publication Date Title
WO2016011306A3 (en) Terminal modifications of polynucleotides
EP3356595A4 (en) Processes for producing nanocellulose, and nanocellulose compositions produced therefrom
EP3089998A4 (en) Sulfite-based processes for producing nanocellulose, and compositions and products produced therefrom
IL235767A (en) Substituted pyrrolidines, pharmaceutical compositions comprising the same and uses thereof
WO2015081257A3 (en) Aminopyridine derivatives as tam family kinase inhibitors
IL256686A (en) Process for preparing lyophilized pharmaceutical compositions and pharmaceutical compositions prepared thereby
WO2015092810A3 (en) Amorphous form of idelalisib
HK1220965A1 (en) Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same abexinostate
WO2015029074A3 (en) Compositions of eltrombopag
IL243435B (en) High potery pancreatin pharmaceutical compositions
EP3003324A4 (en) Pharmaceutical compositions
EP3288636A4 (en) Compositions for the treatment of epistaxis
WO2015042499A3 (en) High cordierite-to-mullite ratio cordierite-mullite-aluminum magnesium titanate compositions and ceramic articles comprising same
WO2015104720A3 (en) Parenteral compositions of bendamustine
HK1222336A1 (en) Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparation
WO2016063289A3 (en) Pharmaceutical tablet compositions comprising rifaximin
WO2014133811A3 (en) Compounds from invasive salvinias and methods of using the same
EP3300474A4 (en) Betacryptoxanthin compositions, processes for preparation and uses thereof
WO2015044434A3 (en) Fluor-9-methyl-β-carbolines
WO2014159501A3 (en) Processes for preparing tetrahydroisoquinolines
EP3057972A4 (en) Novel compositions, uses and methods for their preparation
WO2014122671A3 (en) Solid oral compositions of saxagliptin
WO2014076616A3 (en) Formulations of 5-azacytidine
WO2015092813A3 (en) Lyophilized compositions comprising isomalt
WO2015037017A3 (en) Pharmaceutical compositions of roflumilast and process for preparation thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14871672

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14871672

Country of ref document: EP

Kind code of ref document: A2